P387Knock-in mouse model of PRKAG2 cardiomyopathy (R299Q) exhibits altered Ca2+-dependent cardiac contractility and reduced protein kinase A activity.
Familial hypertrophic cardiomyopathy (HCM) is most commonly caused by mutations in sarcomeric proteins; however, a unifying mechanism of disease pathogenesis has yet to be identified. Beyond the sarcomere, mutations in the gene (PRKAG2) encoding the γ2 subunit of AMP-activated protein kinase (AMPK),...
Main Authors: | Turtle, C, Robinson, P, Yavari, A, Ghaffari, S, Pinter, K, Watkins, H, Redwood, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
DEVELOPMENT AND CHARACTERISATION OF A NOVEL KNOCK-IN MODEL OF PRKAG2 CARDIOMYOPATHY
by: Yavari, A, et al.
Published: (2009) -
<I>PRKAG2</I>-associated hypertrophic cardiomyopathy
by: I. V. Leontyeva
Published: (2022-08-01) -
Altered contractile mechanics and Ca2+ handling contribute to cardiomyopathy pathogenesis
by: Turtle, C
Published: (2015) -
Characterisation of a novel gene-targeted model for PRKAG2 disease
by: Yavari, A
Published: (2013) -
Hypertrophic cardiomyopathy caused by mutations in the <I>PRKAG2</I> gene
by: I. V. Leontyeva, et al.
Published: (2022-09-01)